Tecsys
Buying intent
50 tracked signals | Top 15 topics are below | Engineering and Marketing are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Tecsys's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
5d ago
5d ago
8d ago
8d ago
18d ago
22d ago
18d ago
8d ago
22d ago
5d ago
22d ago
15d ago
15d ago
29d ago
8d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Tecsys
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
14 people across every department at Tecsys, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileTecsys is a global provider of transformative supply chain solutions that equip growing organizations with industry-leading services and tools to achieve operational greatness.
Top accounts researching Tecsys
names withheld on the public pageThese are companies whose own people brought up Tecsys unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
129,094 companies · 649,540 people are researching Artificial Intelligence
Tecsys's own team shows 10 signals on this topic. No one outside Tecsys has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Supply Chain Management4,559 cos · 16,529 people
- Patient Care3,825 cos · 15,451 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 3 people; Engineering — 2 people; Leadership — 2 people; Sales — 1 person; Product — 1 person; HR / Talent — 1 person
What's been said
public posts mentioning TecsysUp to 9 public excerpts naming Tecsys from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
This year's Tecsys User Conference is quickly approaching! We have an incredible lineup of external voices joining us at TUC 2026: leaders, practitioners and partners who are actively shaping the future of supply chain, healthcare and technology. This year’s agenda features perspectives from organizations including Nissan Motor Corporation , Vanderbilt University Medical Center , AdventHealth , UT MD Anderson , Texas Children's Hospital , Prisma Health , Intermountain Health , Wellstar Health System , Medex Life Science Logistics LLC , Kirby Risk , Werner , St. Luke's Health System , Eli Lilly and Company and Schaedler Yesco Distribution , sharing real‑world lessons from continuous innovation, clinical supply chain transformation and modern warehouse operations. We’re also excited to welcome ecosystem and technology leaders from Databricks , Amazon Web Services (AWS) , Locus Robotics , AutoStore™ , Hai Robotics , Zebra Technologies , Terso Solutions , and Avalon CSC , bringing depth across AI, automation, analytics and governance. The strength of the Tecsys community comes to life through these voices and we’re excited for the insight, collaboration and forward momentum they’ll spark at TUC 2026. 📍 Nashville | May 31–June 3 🔗 See the full agenda and register here: https://hubs.ly/Q04cQC4b0 #TUC2026 #SupplyChainLeadership
Apr 2026New drug tariffs are intensifying the challenges pharmaceutical manufacturers are already managing with mounting supply chain pressure, shifting sourcing strategies and rising operational costs. In PharmTech (Pharmaceutical Technology) ’s recent article, Peter Brereton and I share our perspectives on what these tariffs could mean for pharmaceutical manufacturing and supply chains moving forward. As supply and cost conditions change, manufacturers may face increasing uncertainty. The best defense is a resilient supply chain that prioritizes patient continuity through real-time visibility, strong vendor relationships and the ability to respond quickly when a situation arises. Read more about our perspectives here: https://lnkd.in/dcD6NKaW #pharmacy #pharmacysupplychain #technology #healthcare #tariffs #pharmaceutical Tecsys Inc.
Apr 2026